Oscar Health, Inc. (NYSE:OSCR) Receives Average Rating of "Hold" from Brokerages

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has received a consensus rating of "Hold" from the nine brokerages that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, two have given a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $21.56.

OSCR has been the subject of several analyst reports. Jefferies Financial Group initiated coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 target price for the company. Bank of America downgraded Oscar Health from a "neutral" rating to an "underperform" rating and lowered their target price for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Finally, UBS Group began coverage on Oscar Health in a research report on Monday, October 7th. They set a "neutral" rating and a $23.00 target price for the company.

Insiders Place Their Bets

In other news, Vice Chairman Joshua Kushner bought 358,619 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was bought at an average cost of $13.74 per share, for a total transaction of $4,927,425.06. Following the acquisition, the insider now directly owns 5,810,700 shares of the company's stock, valued at $79,839,018. The trade was a 6.58 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Mario Schlosser sold 6,516 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $117,809.28. Following the completion of the sale, the insider now directly owns 81,962 shares in the company, valued at $1,481,872.96. This represents a 7.36 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have purchased 1,055,478 shares of company stock valued at $14,432,852 and have sold 103,610 shares valued at $1,847,519. 25.11% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the stock. State Street Corp raised its holdings in Oscar Health by 6.0% during the third quarter. State Street Corp now owns 5,132,802 shares of the company's stock worth $108,867,000 after purchasing an additional 291,335 shares during the last quarter. Versor Investments LP acquired a new position in Oscar Health in the third quarter valued at $787,000. Janney Montgomery Scott LLC acquired a new position in Oscar Health in the third quarter valued at $988,000. Algert Global LLC increased its stake in Oscar Health by 63.3% in the third quarter. Algert Global LLC now owns 369,685 shares of the company's stock valued at $7,841,000 after purchasing an additional 143,346 shares during the last quarter. Finally, Point72 Asset Management L.P. grew its position in Oscar Health by 30.3% during the third quarter. Point72 Asset Management L.P. now owns 1,212,096 shares of the company's stock valued at $25,709,000 after acquiring an additional 281,858 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Stock Down 7.7 %

Shares of OSCR stock traded down $1.17 during mid-day trading on Friday, reaching $14.12. 5,484,266 shares of the company's stock traded hands, compared to its average volume of 3,477,627. Oscar Health has a 12 month low of $9.70 and a 12 month high of $23.79. The company has a market cap of $3.49 billion, a P/E ratio of -235.29 and a beta of 1.70. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The company's 50-day moving average price is $15.10 and its 200-day moving average price is $16.88.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter in the previous year, the firm earned ($0.29) EPS. The business's revenue for the quarter was up 68.3% on a year-over-year basis. On average, equities analysts expect that Oscar Health will post -0.01 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.